Detalles de la búsqueda
1.
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Clin Infect Dis
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38663013
2.
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
Clin Infect Dis
; 77(4): 593-605, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37052343
3.
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
HIV Med
; 24(1): 27-36, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35527425
4.
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
HIV Med
; 23(8): 895-910, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35233903
5.
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care.
Clin Infect Dis
; 73(11): e4166-e4174, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32706859
6.
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
N Engl J Med
; 375(9): 830-9, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27424812
7.
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure.
Hepatology
; 67(4): 1253-1260, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29152781
8.
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.
Lancet
; 390(10107): 2063-2072, 2017 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28867497
9.
Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis.
Clin Gastroenterol Hepatol
; 16(11): 1811-1819.e4, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29306043
10.
Comorbidities Among US Patients With Prevalent HIV Infection-A Trend Analysis.
J Infect Dis
; 216(12): 1525-1533, 2017 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29253205
11.
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.
JAMA
; 316(2): 191-210, 2016 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27404187
12.
Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America.
Clin Infect Dis
; 58(1): e1-34, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24235263
13.
Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America.
Clin Infect Dis
; 58(1): 1-10, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24343580
14.
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.
Clin Infect Dis
; 58(9): 1297-307, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24457345
15.
Prevention of HIV-1 infection with early antiretroviral therapy.
N Engl J Med
; 365(6): 493-505, 2011 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21767103
16.
Discontinuation of tenofovir disoproxil fumarate for presumed renal adverse events in treatment-naïve HIV-1 patients: meta-analysis of randomized clinical studies.
HIV Clin Trials
; 15(6): 231-45, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25433663
17.
Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.
JAMA
; 312(4): 410-25, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25038359
18.
Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.
J Infect Dis
; 208(1): 32-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23532097
19.
Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings?
Clin Infect Dis
; 57(6): 884-7, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23759345
20.
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.
Lancet
; 379(9835): 2439-2448, 2012 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748591